Smerck the likely winner!

[Anonymous]

Yes , you can see it in their grins!!!!!!!

 

[Anonymous]

It ain't gettin any better than this turd birds.

 

[Anonymous]

Merck Ophthalmics Rep here. You don't want to be a part of this. I've never seen such inept management. The administrative and corporate BS is in a world all it's own. Good luck

 

[Anonymous]

You think you have admin work now, Merck has 30 or so policy letters you have to test out an each one. Then every quarter you have to test out on a couple random things. It's non stop and yes the new management is bad...

 

[Anonymous]

Merck Rep here. Let me quickly review Merck's Ophthalmology prowess:

Inspire - Pays $430M for "commercial force presence" to launch Cosopt PF and Zioptan PF, and with AzaSite @ $60M and growing double digit annually.

Today: AzaSite is <$20M (great job), "commercial force" has seen 50% turnover due to inept home office management, and Cosopt PF and Zioptan PF combined sales were less than $10M in 2012.

We should buy B&L. No telling how far we could drive the sales down in the first two years.

What an utter failure. Thanks Whitehose Station!

 

[Anonymous]

Merck Rep here. Let me quickly review Merck's Ophthalmology prowess:

Inspire - Pays $430M for "commercial force presence" to launch Cosopt PF and Zioptan PF, and with AzaSite @ $60M and growing double digit annually.

Today: AzaSite is <$20M (great job), "commercial force" has seen 50% turnover due to inept home office management, and Cosopt PF and Zioptan PF combined sales were less than $10M in 2012.

We should buy B&L. No telling how far we could drive the sales down in the first two years.

What an utter failure. Thanks Whitehose Station!

Hey, atleast if you are in Whitehouse Station you can go to Polar Cub for a nice ice cream cone

 

[Anonymous]

Id like to add an afternoon FU Merck!